Log In
Print this Print this

Avise SLE

  Manage Alerts
Collapse Summary General Information
Company Exagen Diagnostics Inc.
DescriptionPanel of five serum biomarkers for the differential diagnosis of systemic lupus erythematosus (SLE) and rheumatic diseases
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationAutoimmune, Diagnostic
Indication DetailsDiagnose systemic lupus erythematosus (SLE)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today